Aimed Bio Inc. (KOSDAQ:0009K0)

Aimed Bio Statistics

Total Valuation

Aimed Bio has a market cap or net worth of KRW 3.46 trillion. The enterprise value is 3.30 trillion.

Market Cap	3.46T
Enterprise Value	3.30T

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Aimed Bio has 64.16 million shares outstanding. The number of shares has increased by 18.19% in one year.

Current Share Class	64.16M
Shares Outstanding	64.16M
Shares Change (YoY)	+18.19%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	34.65%
Owned by Institutions (%)	10.47%
Float	19.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	116.84
PB Ratio	19.48
P/TBV Ratio	19.85
P/FCF Ratio	130.43
P/OCF Ratio	128.80
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-76.65
EV / Sales	111.22
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	124.16

Financial Position

The company has a current ratio of 24.62, with a Debt / Equity ratio of 0.01.

Current Ratio	24.62
Quick Ratio	24.47
Debt / Equity	0.01
Debt / EBITDA	0.12
Debt / FCF	0.04
Interest Coverage	153.50

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-0.80%
Return on Capital Employed (ROCE)	4.28%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	50.63
Average Volume (20 Days)	1,284,289

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Aimed Bio had revenue of KRW 29.65 billion and -43.02 billion in losses. Loss per share was -1,065.74.

Revenue	29.65B
Gross Profit	29.65B
Operating Income	7.80B
Pretax Income	-43.03B
Net Income	-43.02B
EBITDA	9.20B
EBIT	7.80B
Loss Per Share	-1,065.74

Balance Sheet

The company has 167.85 billion in cash and 1.11 billion in debt, with a net cash position of 166.75 billion or 2,599.07 per share.

Cash & Cash Equivalents	167.85B
Total Debt	1.11B
Net Cash	166.75B
Net Cash Per Share	2,599.07
Equity (Book Value)	177.84B
Book Value Per Share	3,080.76
Working Capital	163.70B

Cash Flow

In the last 12 months, operating cash flow was 26.90 billion and capital expenditures -336.87 million, giving a free cash flow of 26.56 billion.

Operating Cash Flow	26.90B
Capital Expenditures	-336.87M
Free Cash Flow	26.56B
FCF Per Share	414.00

Margins

Gross margin is 100.00%, with operating and profit margins of 26.30% and -145.09%.

Gross Margin	100.00%
Operating Margin	26.30%
Pretax Margin	-145.12%
Profit Margin	-145.09%
EBITDA Margin	31.04%
EBIT Margin	26.30%
FCF Margin	89.58%

Dividends & Yields

Aimed Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.19%
Shareholder Yield	-18.19%
Earnings Yield	-1.24%
FCF Yield	0.77%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Aimed Bio has an Altman Z-Score of 0.5 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.5
Piotroski F-Score	3